• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Algorithm safely rules out pulmonary embolism in pregnant women

byCaitlyn HuiandDeepti Shroff Karhade
October 25, 2018
in Cardiology, Chronic Disease, Emergency, Obstetrics, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A diagnostic model based on D-dimer measurement, lower limb compression ultrasonography (CUS) and computed tomography pulmonary angiography (CTPA) accurately ruled out pulmonary embolism (PE) in pregnancy.

2. No thromboembolic events occurred at the 3-month follow up for women with PE ruled out by the algorithm.

Evidence Rating Level: 2 (Good)

Study Rundown: During pregnancy, women have an increased risk of PE. It is one of the most common causes of maternal death in developed countries, and therefore it is an important diagnosis to make accurately. Currently, data on the best method of diagnostic management for PE in pregnant women is limited. The authors of this study, therefore, aimed to prospectively validate a diagnostic strategy developed to assess women in pregnancy with suspected PE. Based on their results, they concluded that the algorithm safely rules out PE in pregnant women. Study limitations included that there were several protocol deviations. Furthermore, the sample size was small; consequently, the study may not be generalizable to all populations of pregnant women.

Click to read the study in Annals of Internal Medicine

In-Depth [prospective cohort]: The authors conducted a multicenter, multinational, prospective diagnostic management outcome study. They utilized several factors, including pretest clinical probability assessment, high-sensitivity D-dimer testing, CUS and CTPA to rule out PE in pregnant women. A total of 11 centers in France and Switzerland were included in the study between August 2008 and July 2016. In total, 395 women met inclusion criteria for the study, with PE diagnosed in 28 (7.1%) of the study participants. The rate of symptomatic venous thromboembolic disease was 0.0% (95% CI, 0.0% to 1.0%) among the women that had PE ruled out through the diagnostic work-up and did not receive and anticoagulation treatment.

RELATED REPORTS

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

Discharge rates in American emergency departments unchanged for pulmonary embolism

Testosterone-replacement therapy noninferior to placebo for preventing cardiovascular events

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pulmonary embolism
Previous Post

Intensive blood pressure lowering favored to not induce kidney disease, contrary to prior research

Next Post

Pediatric emergency department visits for homelessness increase after shelter policy change

RelatedReports

#VisualAbstract: Dapagliflozin Reduced Death and Worsening Heart Failure in Transcatheter Aor-tic-Valve Implantation
StudyGraphics

#VisualAbstract: Reduced-Dose Apixaban was Noninferior to Full-Dose for Cancer-Associated Venous Thromboembolism

April 22, 2025
Quick Take: Hospital volume and outcomes for acute pulmonary embolism
Emergency

Discharge rates in American emergency departments unchanged for pulmonary embolism

February 14, 2024
Cardiology

Testosterone-replacement therapy noninferior to placebo for preventing cardiovascular events

July 21, 2023
Nonleg venous thromboses associated with PE, longer ICU stay
Emergency

Indefinite anticoagulation for unprovoked venous thromboembolism is not cost-effective

July 18, 2023
Next Post
Cardiac biomarkers unnecessarily ordered in emergency departments

Pediatric emergency department visits for homelessness increase after shelter policy change

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED

Presence of antiphospholipid antibodies found to be an important independent risk factor for myocardial infarction

Significant number of wrong-patient errors in radiology reports

Quick Take: Use of radiography in patients diagnosed as having acute bronchiolitis in US emergency departments 2007-2015

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • AI Symptom-Checker Could Help Emergency Doctors Prioritize Patients
  • 2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
  • 2 Minute Medicine Rewind May 12, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.